Protagonist Therapeutics: Funding, Investors & Team (Sep 2026)
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
Protagonist Therapeutics has raised $132M across 1 funding round on record, the most recent an undisclosed round of $132M announced in Jun 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Protagonist Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Protagonist Therapeutics Funding Rounds
Protagonist Therapeutics Founders and Leadership Team
Contact details for the Protagonist Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Protagonist Therapeutics Funding Compared to Other Biotechnology Startups
Protagonist Therapeutics' latest round of $132M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Protagonist Therapeutics in Biotechnology and Brisbane
Companies Similar to Protagonist Therapeutics
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Protagonist Therapeutics Funding FAQs
What does Protagonist Therapeutics do?
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
How much funding has Protagonist Therapeutics raised?
Protagonist Therapeutics has raised $132M across 1 round on record. The most recent is an undisclosed round of $132M announced in Jun 2021.
When did Protagonist Therapeutics last raise funding?
Protagonist Therapeutics' most recent funding round on record is an undisclosed round of $132M, announced in Jun 2021.
Who is the CEO of Protagonist Therapeutics?
Dinesh Patel is listed as CEO at Protagonist Therapeutics.
Where is Protagonist Therapeutics headquartered?
Protagonist Therapeutics is based in Brisbane, Queensland, Australia.
How many employees does Protagonist Therapeutics have?
Protagonist Therapeutics is in the 101-250 employee band.
How does Protagonist Therapeutics' funding compare to other Biotechnology startups?
Protagonist Therapeutics' latest round of $132M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Protagonist Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Protagonist Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.